Form 4: Hyperfine COO Thomas Teisseyre Granted Stock Options

Hyperfine's Chief Operating Officer, Thomas Teisseyre, was granted stock options to purchase 500,000 shares of Class A Common Stock on March 28, 2024.

Summary

• Thomas Teisseyre, the Chief Operating Officer of Hyperfine, Inc., was granted stock options on March 28, 2024.
• The options allow him to purchase 500,000 shares of Class A Common Stock at an exercise price of $1 per share.
• The options vest as to 25% on March 28, 2025, and the remaining 75% vests in 36 equal monthly installments thereafter.
• Vesting is contingent upon Dr. Teisseyre's continued service with Hyperfine through each applicable vesting date.
• The options expire on March 28, 2034.

Sentiment

Score: 7

Explanation: The document indicates a standard executive compensation practice, suggesting stability and alignment of interests. It's a neutral-positive event.

Positives

• The granting of stock options to the COO aligns his interests with those of the shareholders.
• The vesting schedule incentivizes continued service and commitment to the company.

Risks

• The value of the stock options is dependent on the future performance of Hyperfine's stock.
• If Dr. Teisseyre leaves the company before the options are fully vested, he will forfeit the unvested portion.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the stock options.

Industry Context

Granting stock options to key executives is a common practice in the industry to incentivize performance and retain talent.

Stakeholder Impact

• Shareholders may view the stock option grant as a positive sign of incentivizing management.
• Employees may see this as a positive sign of investment in leadership.

Key Dates